Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes.
Devillier R, Bramanti S, Fürst S, Sarina B, El-Cheikh J, Crocchiolo R, Granata A, Chabannon C, Morabito L, Harbi S, Faucher C, Santoro A, Weiller PJ, Vey N, Carlo-Stella C, Castagna L, Blaise D. Devillier R, et al. Among authors: faucher c. Bone Marrow Transplant. 2016 Feb;51(2):194-8. doi: 10.1038/bmt.2015.270. Epub 2015 Nov 9. Bone Marrow Transplant. 2016. PMID: 26551778 Clinical Trial.
Early administration of recombinant erythropoietin improves hemoglobin recovery after reduced intensity conditioned allogeneic stem cell transplantation.
Ivanov V, Faucher C, Mohty M, Bilger K, Ladaique P, Sainty D, Arnoulet C, Chabannon C, Vey N, Camerlo J, Bouabdallah R, Viens P, Maraninchi D, Bardou VJ, Esterni B, Blaise D. Ivanov V, et al. Among authors: faucher c. Bone Marrow Transplant. 2005 Nov;36(10):901-6. doi: 10.1038/sj.bmt.1705152. Bone Marrow Transplant. 2005. PMID: 16151421 Clinical Trial.
High-dose weekly liposomal amphotericin B antifungal prophylaxis following reduced-intensity conditioning allogeneic stem cell transplantation.
El-Cheikh J, Faucher C, Fürst S, Duran S, Berger P, Vey N, Stoppa AM, Bouabdallah R, Gastaut JA, Viens P, Blaise D, Mohty M. El-Cheikh J, et al. Among authors: faucher c. Bone Marrow Transplant. 2007 Mar;39(5):301-6. doi: 10.1038/sj.bmt.1705592. Epub 2007 Jan 29. Bone Marrow Transplant. 2007. PMID: 17262059 Clinical Trial.
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT.
Castagna L, Fürst S, Marchetti N, El Cheikh J, Faucher C, Mohty M, Bouabdallah R, Vey N, Stoppa AM, Esterni B, Blaise D. Castagna L, et al. Among authors: faucher c. Bone Marrow Transplant. 2011 Jul;46(7):1000-5. doi: 10.1038/bmt.2010.227. Epub 2010 Oct 4. Bone Marrow Transplant. 2011. PMID: 20921945
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT.
Devillier R, Crocchiolo R, Castagna L, Fürst S, El Cheikh J, Faucher C, Prebet T, Etienne A, Chabannon C, Vey N, Esterni B, Blaise D. Devillier R, et al. Among authors: faucher c. Bone Marrow Transplant. 2012 May;47(5):639-45. doi: 10.1038/bmt.2012.3. Epub 2012 Feb 6. Bone Marrow Transplant. 2012. PMID: 22307016
240 results